Avacta establishes US commercial team
Avacta Group
44.15p
14:54 25/04/24
-2.53%
-1.15p
Affirmer biotherapeutic and reagent developer Avacta Group announced on Monday that it has established a commercial team of three people in the US, including the appointment of Dr Matthew Vincent as vice president therapeutics business development.
FTSE AIM All-Share
752.79
15:30 25/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,649.67
15:30 25/04/24
3.43%
752.17